Target Price Playground
EBARA
$100.00
Forward Projection
If price hits $110 by Jan 15
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Own stock + buy put as insurance against downside.
๐ฏ Target
1-Click Institutional Target Anchors:
60d from today
โ๏ธ Legs
LONG 100 SHARES
@ $100.0 ยท ฮ 1.00
LONG PUT ยท $95 ยท Jan '27
Qty 1 ยท Premium $2.4 ยท ฮ -0.29
P&L at Expiry
Stock (100 sh)
Protective Put
Now
Target
๐ก Stock vs Options at Target
If EBARA hits $110 by Jan 15: the protective put returns +$760 (7.4%) on $10,240 risked, vs +$1,000 (10.0%) for 100 shares on $10,000. Options give 0.7ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (60 days out). P&L shown is the value at expiry if EBARA is at $110.
๐ Projected Return
P&L if EBARA hits $110 by Jan 15
+$760
+7.4% on $10,240 risked
Max Profit
Unlimited
Unlimited upside (minus put cost)
Max Loss
โ$740
Put floors you at $95
Break-even
$102.40
+2.4% from spot
Prob. of Profit at Expiry (PoP)
42.3%
Above breakeven ($102.40)
ยท Touch Target: 41%
30-Day Theta Burn (If Flat)
โ$93
0.9% of entry cost ยท Daily ฮ: $-3.1/day
Net ฮ / ฮ / V
70.66 / -3.1 / 13.96
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| EBARA Price | Today | Dec 6 | Dec 26 | Jan 15 (exp) |
|---|---|---|---|---|
| $80 (-20%) | -$767 | -$770 | -$762 | -$740 |
| $85 (-15%) | -$691 | -$722 | -$747 | -$740 |
| $90 (-10%) | -$546 | -$604 | -$676 | -$740 |
| $95 (-5%) | -$315 | -$387 | -$486 | -$740 |
| $98 (-2%) | -$135 | -$207 | -$301 | -$440 |
| $100 (0%) โ spot | +$0 | -$68 | -$153 | -$240 |
| $102 (+2%) | +$147 | +$85 | +$13 | -$40 |
| $105 (+5%) | +$385 | +$334 | +$283 | +$260 |
| $110 (+10%) โ target | +$821 | +$788 | +$764 | +$760 |
| $115 (+15%) | +$1,287 | +$1,270 | +$1,261 | +$1,260 |
| $120 (+20%) | +$1,772 | +$1,763 | +$1,760 | +$1,760 |
Uses EBARA's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.